CornerCap Investment Counsel »

Cue Biopharma shares owned by CornerCap Investment Counsel

Quarter-by-quarter ownership of Cue Biopharma (CUE) shares owned by CornerCap Investment Counsel from 13F filings

Historical chart of CornerCap Investment Counsel investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by CornerCap Investment Counsel consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by CornerCap Investment Counsel

Quarter filed Position value Share count Share price at filing
2023-12-31 $153k 58k 2.64
2023-09-30 $133k 58k 2.30
2023-06-30 $214k 59k 3.65

More positions owned by CornerCap Investment Counsel

Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Chevron Corporation (CVX)
Facebook Inc cl a (META)
Alphabet Inc Class A cs (GOOGL)
Cisco Systems (CSCO)
Apple (AAPL)
CSX Corporation (CSX)
Microsoft Corporation (MSFT)
Emerson Electric (EMR)
Merck & Co (MRK)
Booking Holdings (BKNG)
Fnf (FNF)
Bristol Myers Squibb (BMY)
Intel Corporation (INTC)

View all positions for CornerCap Investment Counsel

Top funds holding Cue Biopharma

Vanguard Group
Bleichroeder
Robertson Stephens Wealth Management
Dimensional Fund Advisors
Monaco Asset Management SAM
Millennium Management
Bank of America Corporation
Sigma Planning
GSA Capital Partners
Stifel Financial
Charles Schwab Investment Management
Good Life Advisors
UBS Group
Bank of New York Mellon
HighTower Advisors

View all funds holding Cue Biopharma